Obstructive sleep-disordered breathing (SDB) is common in children and varies along a continuum of upper airway obstruction from primary snoring to upper airway resistance syndrome (UARS) to obstructive sleep apnea syndrome (OSAS). Primary snoring is characterized by frequent snoring without ventilatory abnormalities or obvious sleep disruption and affects 5%--10% of children. UARS differs from primary snoring in that sleep is fragmented by arousals, while the severe OSAS is characterized by hypoxia and sleep fragmentation, affecting 1%--4% of children.[@b1-nss-2-159] There is now convincing evidence that SDB is associated with neurocognitive and behavioral deficits, particularly those of hyperactivity, inattention, memory, learning, executive functioning, and general cognitive capacity.[@b2-nss-2-159] In contrast, there is less convincing evidence that treatment of SDB (ie, adenotonsillectomy) reverses deficits. This remains to be completely investigated, as do the correlates of SDB and their association with neurocognitive and behavioral deficits.

Charles Dickens,[@b3-nss-2-159] in his book *The Posthumous Papers of the Pickwick Club*, is credited with an early description of child SDB, with the fat boy Joe often falling asleep in strange or inappropriate places and snoring when he was sleeping, as having slow perception, bizarre and aggressive behavior, being red-faced with swollen legs and dividing "...his time into small alternate allotments of eating and sleeping." Over 50 years later, William Osler[@b4-nss-2-159] in the 1892 edition of *The Principles and Practice of Medicine* presciently described a child with suspected SDB, as responding "...slowly to questions and may be sullen and cross...The influence on the mental development is striking...It is impossible for them to fix the attention for long at a time". Similarly, William Hill[@b5-nss-2-159], reporting in the British Medical Journal in 1889, noted symptoms of "...backwardness and stupidity..." in children with adenotonsillar enlargement. Despite these seminal observations, it took another 8 decades before the impact of childhood SDB on daytime cognitive performance and behavior was formally investigated by Guilleminault et al[@b6-nss-2-159] in 1976. These authors reported that the majority of children with OSAS in their small sample of eight children had excessive daytime sleepiness and learning difficulties at school. Further, children attending school were reported by their teachers to be hyperactive, to be inattentive, and to have a general decrease in intellectual ability while half the children were receiving mental health intervention for "emotional problems". Despite the small sample size and lack of controls, this initial study demonstrated that children with SDB have substantive behavior and cognitive performance deficits -- a finding that was largely overlooked for the next 2 decades. In 1982, Guilleminault et al[@b7-nss-2-159] published a report of 25 snoring children who on nocturnal polysomnography (PSG) did not meet the criteria for OSAS, but demonstrated significantly increased esophageal pressure during sleep when compared with controls, suggesting UARS. Notably, these children were hyperactive (48%), aggressive (40%), withdrawn (40%), and clumsy (44%). All the school-aged children in remedial education programs were reported to have learning problems (40%). Further, eight children were on methylphenidate treatment for hyperactivity, and 19 children had a current or previous referral to a psychiatrist or psychologist. Although only the second investigation in this area, this study indicated that even mild forms of SDB may be associated with significant behavioral and cognitive sequelae.

Until the mid-1990s, there was little additional research examining cognitive and behavior sequelae in children with SDB, with the focus only returning in the early 2000s. A series of reviews undertaken between 2001 and 2006[@b2-nss-2-159],[@b8-nss-2-159]--[@b12-nss-2-159] have consistently identified cognitive deficits in attention, memory and learning, and general intelligence, and behavioral problems of attention, hyperactivity, and aggression, with the later reviews also including anxiety, depression, and emotional instability. However, the deficits identified in these earlier studies reflect the focus of researchers, with several domains notably absent or underexplored from examination such as sensorimotor function, language skills, and visuospatial ability. The early reviews also revealed substantial methodological limitations in the field, including inadequate sampling methods; inappropriate or inadequate statistical analysis; small sample sizes; lack of control data; inadequate methods for diagnosis of SDB status; and a failure to consider potential confounders such as socioeconomic and demographic status, obesity, family history, chronicity of disease, age, gender, comorbid disorders, ethnicity, parental education, and other environmental factors. An especially important limitation is the failure by most studies to consider the interplay between SDB, hyperactive behavior, and ADHD, the delineation of which appears to be vital in helping to clarify the unique role SDB plays in the development of hyperactive behavior.[@b13-nss-2-159]

A critical review of the literature
===================================

Given the recent increase in research investigating the cognitive and behavioral deficits among children with SDB and the many limitations evident in this research, it is important that strict evaluation guidelines be established. A parallel need has emerged in the adult OSAS field resulting in rigorous exclusion criteria, which has enabled better characterization of the pattern of cognitive domains impacted by OSAS and identification of those cognitive domains that improve with treatment. For example, Aloia et al[@b14-nss-2-159] excluded studies specifically recruiting non-OSAS participants, without verification of OSAS by PSG; recruiting medical populations with OSAS, including children or adolescents and exclusively patients with central sleep apnea; and assessing a single cognitive domain or using nonvalidated instruments. In doing so, a clear pattern of spared global intelligence, but impaired attention, executive functioning, memory, and psychomotor functioning, was characterized in OSAS adults, with treatment response in all domains except in psychomotor functioning. Imposing similar exclusions and critically reviewing the current child-based literature are also likely to clarify the pattern of neurocognitive and behavioral problems and treatment response in children with SDB.

Data for the current review included empirical studies published in peer-reviewed journals up until November 2009. A literature search using PubMed and PsychInfo online databases was made using combinations of the following search terms: sleep, children, snoring, apnea, cognition, neurocognition, cognitive, behavior, and behavioral. Existing reference lists from the published studies were also reviewed to identify additional relevant studies. Studies with no English version, book chapters, review articles, dissertations, abstracts, letters to the editor, and any nondata analytic reports were excluded. Initially, 95 studies were identified for consideration (see [Appendix A](#t5-nss-2-159){ref-type="table"}). To provide a more critical review of the literature, studies were included only if they met the following criteria:

1.  SDB status was verified by overnight laboratory or home-based multichannel PSG \[including at least oximetry, airflow, electrocardiogram, thoracic and abdominal movements, and video monitoring in the absence of electroencephalogram (EEG)\].

2.  Special medical populations with SDB were excluded (such as those with Down's syndrome or Pierre Robin sequence).

3.  Study participants aged over 18 years were excluded.

4.  Validated measures of neurocognitive performance (excluding school grades) and behavior were used.

5.  Data of control group or standardized normative data were used while reporting group performance (except when reporting the association between SDB severity and performance).

To facilitate a better understanding of the contribution of SDB to neurocognitive and, likewise, behavioral deficits, these two broad areas have been separately examined. Twenty-eight studies that report neurocognitive findings ([Table 1](#t1-nss-2-159){ref-type="table"}) and 21 reporting behavioral findings ([Table 2](#t2-nss-2-159){ref-type="table"}) with 12 overlapping studies were included. In addition, we further separated the studies into those that have examined the association between SDB severity and neurocognition (n = 13; [Table 3](#t3-nss-2-159){ref-type="table"}) and between SDB and behavior (n = 12; [Table 4](#t4-nss-2-159){ref-type="table"}), with seven overlapping studies.

Neurocognitive performance deficits in children with SDB
--------------------------------------------------------

A summary of neurocognitive domains assessed by studies meeting this review's criteria is presented in [Table 1](#t1-nss-2-159){ref-type="table"}. All studies report one or more neurocognitive deficits in children with SDB, with the frequency of affected domains ranging from 40% for verbal intelligence to 71% for attention. The most frequently assessed domain was intelligence (including global, verbal, and nonverbal intelligence; 24 studies) and the least sensorimotor functioning (six studies). Most studies report significant deficits in intelligence, attention, and executive function and less commonly deficits in memory, visual--spatial ability, language skills, and sensorimotor functions. Notably, there does not appear to be a dose-response effect, with the magnitude of deficits comparable in primary snoring and OSAS.

Despite 13 of 20 studies reporting that global intelligence scores were significantly lower in children with SDB compared with controls, mean scores for children with SDB in 11 of these studies were within the normal range and less than one standard deviation below the mean in only two studies.[@b10-nss-2-159],[@b15-nss-2-159] In addition, a number of studies report the mean global intelligence scores in control groups at or above the upper limit of the normal range.[@b16-nss-2-159]--[@b19-nss-2-159] It could be argued that a recruitment bias in control samples may force the difference observed in these studies; however, performance in these control samples is consistent with that of healthy children in other large studies.[@b20-nss-2-159] The pattern of findings for global intelligence parallels those for other neurocognitive domains, with the performance reduced in children with SDB but generally in the normal range. Of the two exceptions that report substantively reduced global intelligence quotient (IQ) scores, one study exclusively recruited children with low socioeconomic standing, while the second included children with severe SDB symptoms. Compared with children from high socioeconomic status (SES), children with low SES have worse neurocognitive performance when sleep is disturbed, but similar performance when sleep is undisturbed.[@b21-nss-2-159] Low SES is also associated with an increased risk for behavioral and neurocognitive deficits among children with SDB.[@b22-nss-2-159],[@b23-nss-2-159] Taken together, these results suggest an interaction between SDB and SES, which may place subgroups of children at higher risk for neurocognitive and behavioral impairment. The results also highlight the problems of evaluating neurocognitive performance and the need to control for confounds, such as SES, in analyses.

In addition to deficits in intelligence, majority of studies also report that children with SDB have reduced executive function characterized by problems with planning and strategizing, but not with inhibition.[@b10-nss-2-159],[@b18-nss-2-159],[@b24-nss-2-159]--[@b27-nss-2-159] This suggests a specific pattern of executive dysfunction among children with SDB and distinct to findings in ADHD, where deficits in inhibition are considered to be a core feature.[@b28-nss-2-159] The final area of consistently reduced performance in children with SDB is attention. A primary deficit in attentional capacity has been proposed to underlie both lower and higher order neurocognitive deficits in adults with OSAS.[@b29-nss-2-159] It is considered that attentional capacity is sensitive to sleep fragmentation and likely to be evident across the SDB spectrum. In addition, attentional capacity is considered to underpin higher order neurocognitive processes such as executive functioning. Despite the appeal of these hypotheses, the magnitude of neurocognitive deficits is generally comparable in children with mild SDB (primary snoring) and children with severe SDB (OSAS).[@b18-nss-2-159] In the few cases of a difference between SDB groups and contrary to expectations, children with primary snoring generally perform worse than children with OSAS.[@b25-nss-2-159] As a corollary, a similar pattern of finding regarding SDB severity to those reported for neurocognitive functioning is evident in behavioral functioning.[@b30-nss-2-159] Attentional deficits in children with SDB are typically for visual not auditory, and while generalization is limited due to the variation of tests used on balance SDB children have problems with maintaining sustained visual attention.[@b10-nss-2-159],[@b17-nss-2-159],[@b18-nss-2-159],[@b24-nss-2-159],[@b26-nss-2-159],[@b27-nss-2-159],[@b31-nss-2-159]--[@b34-nss-2-159] As attention deficits have been found to mediate deficits in other neurocognitive functions among adults with SDB,[@b29-nss-2-159] it will be important for future research to investigate the interaction between attention and executive functioning as this may explain deficits in other neurocognitive domains.

Associations between SDB severity and neurocognitive performance
----------------------------------------------------------------

Only a small number of studies have examined the association between SDB severity and neurocognitive performance, and the majority of these have failed to demonstrate a significant dose-response association ([Table 2](#t2-nss-2-159){ref-type="table"}). The only finding with any consistency is the reported significant associations between increased SDB severities with reduced executive function (3 of 5 studies). Examination of the studies revealed no obvious factors to explain why some studies have reported significant and others nonsignificant correlations.

The lack of significant associations raises concerns about the assumption of a temporal relationship between SDB severity and neurocognitive performance. Because of the relative difficulty in testing neurocognitive functioning in young children, SDB studies are typically restricted to children \>5 years. However, the incidence of SDB symptoms peaks in preschool children,[@b35-nss-2-159] suggesting that children with SDB are likely to have been symptomatic for longer periods before testing. As such, it is possible that neurocognitive deficits secondary to SDB may develop in early life explaining the lack of correlation between SDB severity and neurocognitive measures found later in life. This suggests that the relationship may be more related to the age of disease onset or disease duration rather than the current SDB severity. Cumulative effects or earlier point of insult during a period of rapid neural development may result in greater severity and a range of deficits.

The contention that neurocognitive deficits may occur shortly after birth in infants with SDB is supported by at least two studies. Montgomery-Downs and Gozal[@b36-nss-2-159] reported that in 35 healthy infants (mean age = 8.2 months), higher snoring-associated arousal scores were associated with lower neurocognitive development scores (*r* = −0.43). Of note, however, is that Montgomery-Downs and Gozal's study neither did include infants with OSAS in the sample nor did they differentiate between nonsnoring controls and primary snorers in their analyses, thus limiting the examination of any dose effect in the association between SDB severity and severity of neurocognitive deficits. Hunt et al[@b37-nss-2-159] examined the relationship between cardiorespiratory events (ie, oximetry-defined apnea) and neurocognition at 2 years of age in a combined sample of 256 healthy infants with a history of apparent life-threatening events and their siblings. Infants with ≥5 compared with \<1 "apnoeic/bradycardic" events per hour had lower mental development scores. Additional analysis of the correlations between SDB severity and neurocognitive performance by our group[@b18-nss-2-159] in 46 children with SDB has revealed that correlations were stronger and significant in children aged 3--4 years, but not in 5--7 and 8--12 year olds (see [Figure 1](#f1-nss-2-159){ref-type="fig"}). In sum, these studies support the hypothesis that SDB in early infancy results in measurable developmental deficits.

Problematic behavior in children with SDB
-----------------------------------------

In general, less than half the studies report increased problematic behavior in children with SDB ([Table 3](#t3-nss-2-159){ref-type="table"}). The most frequently reported problematic behaviors were somatic complaints, depression, and social problems. This is in contrast to the widely held belief that hyperactivity, aggression or oppositional behavior, and inattention are predominant in children with SDB. The inconsistency in results combined with the results of this review suggests that problematic behavior in children with SDB may be better explained by comorbid sleep problems.[@b38-nss-2-159] The incidence of comorbid sleep disorders in children with SDB (eg, sleep walking and night terrors) is high.[@b39-nss-2-159],[@b40-nss-2-159] This raises the importance of controlling the effect of comorbid sleep problems on behavior in future studies.

There is some evidence that children with SDB are sleepier than controls, which may contribute to increased problematic behavior. Melendres et al[@b41-nss-2-159] administered the Epworth Sleepiness Scale to measure the level of daytime sleepiness in 108 children with suspected SDB and 72 controls matched for age, gender, race, and SES. Children with suspected SDB were rated as sleepier and more hyperactive than controls; however, no difference in sleepiness scores was found between the children with primary snoring versus OSAS. It is noteworthy that the Epworth Sleepiness Scale is reported not to correlate with objective measures of sleepiness in children with SDB,[@b42-nss-2-159] raising the need for validation of an age-specific sleepiness scale before conclusions about such results can be drawn. Chervin et al[@b43-nss-2-159] used the Multiple Sleep Latency Test (MSLT) in 78 children with SDB before and after adenotonsillectomy and compared results with those of 27 controls of similar demographic status from an unrelated hospital clinic. The MSLT is reported to be sensitive to sleepiness in children from 3 years of age.[@b44-nss-2-159] Chervin's group found that children scheduled for adenotonsillectomy demonstrated increased SDB severity and reduced MSLT times before surgery on the day following PSG, indicating increased sleepiness.

Associations between SDB severity and problematic behavior
----------------------------------------------------------

As with neurocognition, there is little evidence of an association between SDB severity and problematic behavior ([Table 4](#t4-nss-2-159){ref-type="table"}). Only three of 12 studies report any significant association, with all three reporting that SDB severity was associated with increased aggression or oppositional behavior and two studies reporting that SDB severity was associated with increased depression. This suggests the possibility of a third factor such as sleepiness modulating the association between SDB and behavior. The two previously mentioned studies assessing sleepiness in children with SDB report significant linear correlations between SDB severity and sleepiness.[@b41-nss-2-159],[@b43-nss-2-159] Both these studies examined only a limited range of other behaviors (confined to measures of attention and hyperactivity); however, no associations of problematic behavior and SDB severity were reported.

Effects of treatment on neurocognition and behavior
===================================================

Given the daytime decrements outlined earlier, there is currently great interest in demonstrating that treatment of childhood SDB reverses not only the nocturnal ventilator abnormalities but also the behavioral and neurocognitive deficits. Our review identified 30 treatment studies: 27 adenotonsillectomy studies (including two studies that compared tonsillectomy with intracapsular tonsillectomy or tonsillotomy), two tracheotomy studies, and one study that used unspecified surgery and continuous positive airway pressure ([Appendix B](#t6-nss-2-159){ref-type="table"}). The impact of treatments other than adenotonsillectomy on neurocognitive and behavioral functions in children is largely unknown and is an area deserving further study. Overall, the treatment (by adenotonsillectomy) is reported to improve attention, memory, and school performance and reduce hyperactivity, aggression or oppositional behavior, inattention, somatic complaints, and anxiety.

Neurocognitive performance after treatment for SDB
--------------------------------------------------

One of the early proponents of adenotonsillectomy for childhood OSAS was William Osler who in 1919 said, "If the tonsils are large and the general state is evidently influenced by them they should be at once removed";[@b67-nss-2-159] however, it was not until the 1970s that researchers began examining its effect on neurocognitive functioning. Early studies of treatment for SDB in children are anecdotal in nature, but all report improved neurocognitive and behavioral functioning. For example, in the landmark study by Guilleminault et al[@b6-nss-2-159] adenotonsillectomy reduced daytime sleepiness and improved school performance in all eight children and normalized academic performance in three of five children experiencing learning difficulties. In 1982, Guilleminault et al[@b7-nss-2-159] again demonstrated that adenotonsillectomy led to improved school performance in all cases 3 months postsurgery. Before treatment, all children with SDB were placed in remedial school classes and only two remained in these classes for 6 months after treatment. Tiredness was also reduced as measured by MSLT scores. In the same year, Brouillette et al[@b68-nss-2-159] reported five of 22 children with SDB, behavioral disturbance, excessive sleepiness, and developmental delay. All demonstrated improved daytime functioning following surgical treatment.

From 1990 to 1996, results from a series of studies conducted at the Osler Chest Unit in oxford demonstrated improved questionnaire-based reports of attention and vigilance, following either adenotonsillectomy for SDB or spontaneous resolution of snoring.[@b69-nss-2-159]--[@b71-nss-2-159] In 1998, Gozal[@b72-nss-2-159] confirmed the benefits of adenotonsillectomy in a large sample of children recruited from a community rather than a hospital's sleep clinic. In an innovative study, he examined the academic performance in 297 first-grade children who ranked in the lowest 10% of their class and identified 54 children with SDB (confirmed by overnight oximetry and monitoring of transcutaneous partial pressure of carbon dioxide). Of this subset, 24 underwent adenotonsillectomy and by second grade demonstrated improved academic performance compared with both untreated children and children without evidence of SDB, but who also performed in the lowest 10% of their class. Two years later, another group reported improved daytime sleepiness and school performance among 45 children aged 2.5--15.5 years, following removal of adenoids and/or tonsils for OSAS confirmed by PSG.[@b73-nss-2-159] A number of reviews have since confirmed the benefits of adenotonsillectomy as a treatment for upper airway obstruction, estimating that ventilatory function is normalized in on average 66% to 83% of cases following surgery[@b74-nss-2-159],[@b75-nss-2-159] and, likewise, postadenotonsillectomy gains in neurocognitive and behavioral performance.[@b76-nss-2-159],[@b77-nss-2-159] However encouraging, the interpretation of the literature needs to be treated with caution as few studies have adequately addressed methodological limitations especially assessing children with PSG at follow-up and lack of control data. As outlined in recent studies, it is estimated that up to 33% of children on average continue to obstruct postadenotonsillectomy, potentially confounding postoperative comparisons. As well, without a control group it is difficult to exclude learning effects, which may explain treatment gains, particularly if there is a short time between testing. After applying the strict criteria described earlier, we were able to include only two studies examining the impact of adenotonsillectomy on neurocognitive function[@b18-nss-2-159],[@b43-nss-2-159] and two studies examining the impact on behavior[@b43-nss-2-159],[@b66-nss-2-159] in this review. Below is a brief discussion on relevant treatment studies, followed by the results of this review for neurocognitive and behavior functions.

A range of neurocognitive and behavior functions were assessed by Owens et al[@b46-nss-2-159] in 18 children with OSAS. Eight of these children subsequently underwent adenotonsillectomy and were reassessed 6--12 months postsurgery. Tests of executive function (verbal fluency) were improved following surgery. Although no significant change in general neurocognitive ability, language skill, memory, visual perception, motor ability, or behavior was observed, effect sizes were reported to be large for tests of attention and visualmotor ability. Hansen and Vandenberg[@b47-nss-2-159] examined another small group of children with OSAS and demonstrated that memory performance was improved 5 months after treatment. Improvements in visual attention and general neurocognitive performance approached statistical significance in this study; however, auditory attention (which was rated as impaired in comparison to normative data before treatment) remained unchanged. In 2003, Friedman et al[@b16-nss-2-159] assessed neurocognitive function using standardized tests in 39 children with OSAS compared with 20 controls. Twenty-seven children with OSAS and 14 controls were reassessed 6--10 months after adenotonsillectomy. Significant improvement was seen in treated children for perceptual ability, concept formation, verbal and spatial memory, analytical thinking, and total intelligence. No improvement was seen for vocabulary and memory for numbers. Avior et al[@b79-nss-2-159] assessed attention in 19 children with SDB before and 2 months after adenotonsillectomy. Attention improved in all except one participant postoperatively, demonstrating that neurocognitive changes may occur within the first 2 months after treatment; however, the potential impact of a learning effect needs to be considered.

In the first study to examine preschool children, Harvey et al[@b80-nss-2-159] assessed mental ability in 24 children with OSAS before and 6 months after adenotonsillectomy. Results were compared with 15 age- and gender-matched children with OSAS but who did not receive any intervention. Adenotonsillectomy did not result in any change in mental ability scores and no between-group differences were observed, raising questions about the optimal timing of treatment to prevent daytime deficits. In 2005, Montgomery-Downs et al[@b15-nss-2-159] compared data from 19 preschool children with OSAS to 19 matched nonsnoring controls on measures of general intellectual ability, language development, and memory at baseline and 3--6 months postadenotonsillectomy for those with OSAS. At baseline, general intellectual ability was lower in OSAS children and improved in 16 children postoperatively. No group differences were found pre- or postsurgery for measures of memory and language; however, executive function performance was impaired in OSAS subjects both before and after treatment. Combined, these results suggest that general neurocognitive ability and executive deficits are evident among preschool-aged children with OSAS, and some of these deficits may not be remediated 3--6 following treatment.

Galland et al[@b32-nss-2-159] report objective measures of sustained attention and parental reports of behavior in 61 children with suspected SDB pre- and 3-months postsurgery. Visual continuous performance testing revealed increased inattention and impulsivity among children before surgery and significant improvement following adenotonsillectomy. In contrast, performance on an auditory continuous performance test showed no significant deviation from normative data and no change postsurgery. Similarly, Li et al[@b53-nss-2-159] assessed attention and impulsivity among 40 children with suspected SDB before and 6 months following adenotonsillectomy. Response time and indications of ADHD were improved postoperatively; however, there was no significant association between change in SDB severity and change in test scores. In an assessment of cerebral blood flow and neurocognition in children with mild SDB compared with controls, Hogan et al[@b81-nss-2-159] found some evidence of improved processing speed and visual attention among children with SDB; however, measures of executive function remained in deficit postadenotonsillectomy. Using anecdotal parental report of neurocognitive performance and behavior, Moré et al[@b82-nss-2-159] found a large proportion of parents of 44 children with SDB reported resolved problems of speech delay, poor school performance, poor concentration, and poor memory. More recently, Lundeborg et al[@b83-nss-2-159] reported that language deficits (phonological processing) were improved following both tonsillectomy and partial resection (tonsillotomy) in preschool-aged children with SDB; however, deficits compared with controls were still evident at 6 months following treatment.

In one of only two studies to meet the inclusion criteria set for this review, Chervin et al[@b43-nss-2-159] compared measures of behavioral hyperactivity, psychiatric morbidity, sleepiness, and test of attention between 78 children scheduled for adenotonsillectomy and 27 children for unrelated surgery (77 vs 23 at follow-up). One year after surgery, children who underwent adenotonsillectomy demonstrated improvement in attention deficits and reduction in sleepiness to levels equivalent to controls. No association between attention and any PSG variable was observed; however, sleepiness (as assessed on MSLT) was significantly associated with multiple indications of SDB, including apnea index and oxygen saturation nadir. Controls in this study included cases demonstrating clinically significant levels of SDB, and these results may, therefore, not truly represent the differential neurocognitive and behavioral aspects of children with and without SDB. In contrast, in the only other study meeting the inclusion criteria, Kohler et al[@b18-nss-2-159] found wide-ranging neurocognitive deficits primarily in global intelligence; planning; working memory; and memory for narrative, visual attention, and language development among 44 children with SDB both at baseline and 6 months following adenotonsillectomy compared with 48 controls. It may be that deficits take longer than 6 months to normalize, but these findings raise concerns regarding the permanency of deficits.

Despite the pattern of treatment response for a number of neurocognitive performance domains in children with SDB, residual deficits in memory, executive functioning, and language development are also evident. In addition, only two studies met the strict inclusion criteria used in this review (which emphasized valid assessment of SDB severity, neurocognitive performance, and inclusion of control data at baseline and follow-up assessments), themselves presenting contrasting results. Clearly, further well-controlled treatment studies are required before informed decisions about treatment efficacy for remediating neurocognitive deficits can be made.

Behavior after treatment for SDB
--------------------------------

Although commonly reported in the positive, relatively few studies have examined whether problematic behavior is reduced in children with SDB following treatment. In 1982, Guilleminault et al[@b7-nss-2-159] reported that the behavior improved 3-months postadenotonsillectomy and by 6 months none of the eight children with SDB previously taking methylphenidate for hyperactivity were still medicated. Brouillette et al[@b68-nss-2-159] also reported reduced hyperactivity, reduced aggression, and reduced daytime sleepiness following surgical treatment for SDB among five children. Goldstein et al[@b84-nss-2-159],[@b85-nss-2-159] demonstrated in a combined cohort of 79 children that adenotonsillectomy improved anxiety, depression, thought problems, and total problematic behavior; however, reports of improvements in withdrawn behavior, somatic complaints, and attention problems were inconsistent. Mitchell and Kelly[@b64-nss-2-159] assessed behavior in 23 children with OSAS and reported postadenotonsillectomy improvements at 6 months and again at 9--18 months in aggression, hyperactivity, somatic complaints, depression, and atypicality. Galland et al[@b32-nss-2-159] report in 61 children with SDB that adenotonsillectomy reduced hyperactivity, aggression, depression, somatic complaints, attention problems, and composite scores for internalizing, externalizing, and total problems. Roemmich et al[@b86-nss-2-159] report reduced hyperactivity in 54 children with OSAS 12 months postadenotonsillectomy. Apart from problems of aggressive behavior, Li et al[@b53-nss-2-159] also report in 40 children with SDB substantial reduction in a broad range of internalizing and externalizing behavior problems 6 months following adenotonsillectomy. Wei et al[@b87-nss-2-159],[@b88-nss-2-159] completed a 6-month and a 2.4- to 3.6-year follow-up of 71 and 44 children with SDB, respectively, and reported postadenotonsillectomy improvement in inattention, hyperactivity, and oppositional behavior. Moré et al[@b82-nss-2-159] report that aggressiveness and hyperactivity were reduced 9 months after adenotonsillectomy, while Ericsson et al[@b89-nss-2-159] report reduced somatic complaints following either tonsillotomy or tonsillectomy in 67 children with SDB; mixed results for symptoms of aggression, anxiety, inattention, and social problems; and no change for withdrawn behavior and thought problems. In contrast, Constantin et al[@b65-nss-2-159] report no gains postadenotonsillectomy compared with retrospective ratings of behavior. Tran et al[@b78-nss-2-159] compared behavior in 42 children pre- and postadenotonsillectomy for OSAS and 41 children undergoing unrelated surgery. The authors report that children with OSAS demonstrated a greater improvement than controls in thought problems, somatic complaints, internalizing behaviors, and total behavioral problems. Despite the encouraging results, and similar to the caveats noted for the neurocognitive studies, relatively few of the studies examining the impact of adenotonsillectomy on behavior have included PSG and control data at follow-up.

Both studies to assess behavior response to treatment and meet the inclusion criteria in this review are from the same sample of children. Chervin et al[@b43-nss-2-159] found that before adenotonsillectomy, 78 children with SDB were rated as more hyperactive and more likely to have attention-deficit or hyperactivity disorder compared with 23 controls. One year after surgery, children who underwent adenotonsillectomy demonstrated hyperactivity levels equivalent to controls. Dillon et al[@b66-nss-2-159] found reduced oppositional behavior in children with SDB, but found problems with anxiety and depression following treatment.

Largely consistent with previous reviews, reductions in hyperactivity, aggression or oppositional behavior, and somatic complaints seem evident following treatment for SDB. There is also some evidence to suggest that the closely-related symptoms of depression and withdrawn behavior are reduced posttreatment. In contrast, the evidence that parentally reported inattention and anxiety improves after treatment is less convincing.

Possible mechanisms
===================

It is generally believed that the neurocognitive and behavioral deficits seen in children with OSAS are due to intermittent nocturnal hypoxia or fragmentation of sleep and that the failure to normalize these daytime deficits postadenotonsillectomy is secondary to the failure either to adequately correct fragmentation or hypoxia or to correct a persisting neurological dysfunction. A major difficulty for research in this area is that there is little correlation between the findings on PSG, such as cortical arousals and apnea or hypopnea indices, and changes in neurocognition or behavior.[@b90-nss-2-159] In addition, as daytime deficits are seen in children with mild upper airway obstruction, it is likely that explanatory polysomnographic changes will be subtle. The investigation of the etiology of these neurocognitive and behavioral deficits, therefore, requires a focus on more sensitive methods of evaluating sleep fragmentation and the effects of intermittent hypoxia on cerebral molecular structure and function.

As fragmentation of sleep by upper airway obstruction-induced arousals is less frequent in childhood OSAS, attention has been focused on more detailed evaluation of their sleeping EEG. The cyclic alternating pattern (CAP) is a measure of sleep microstructure, quantifying phasic EEG activity across the night to derive an estimate of sleep stability and fragmentation.[@b91-nss-2-159] A1 phase frequency of CAP (a protective reaction of the sleeping brain) has been shown to be reduced in children with SDB[@b92-nss-2-159] and A2 phases (mild cortical activation) increased among children with OSAS compared with controls.[@b93-nss-2-159] A rebound in A1 indices was observed among children with OSAS 1 year after rapid maxillary expander treatment; however, other measures such as A2 frequency remained unchanged.[@b94-nss-2-159] The functional significance of these differences is yet to be determined as is the association with neurocognitive performance and behavior. An initial study in children with Asperger syndrome has found strong correlations between neurocognitive performance, behavior, and a number of CAP indices, providing encouraging results for future investigation in children with SDB.[@b95-nss-2-159]

Chervin et al[@b96-nss-2-159] quantified variations in EEG power frequencies with the respiratory cycle in children with SDB \[called the "respiratory cycle -- related EEG changes" (RCREC)\]. Changes in RCREC were associated with subjective sleepiness in children with SDB,[@b97-nss-2-159] and postoperative changes in RCREC correlated more strongly with changes in daytime sleepiness and attention compared with changes in apnea and hypopnea frequency.[@b98-nss-2-159] This suggests that more detailed evaluation of sleeping EEG recordings in children using these new methods may yield new information on the association between functional EEG changes and daytime deficits.

Intermittent hypoxia results in oxidative stress and induces a proinflammatory response. In animal models this leads to apoptosis and disorganization in cerebral regions which underpin learning and memory. Neuroimaging studies in adults with SDB demonstrate a range of cerebral abnormalities including reduced hippocampal volume; frontal white matter abnormalities among SDB patients at greater risk of vascular disease; changes to motor, sensory, and autonomic control regions of the brain during wakefulness; absence of prefrontal activation in association with poor working memory performance; and compensatory recruitment of brain regions during a verbal learning test.[@b99-nss-2-159]--[@b102-nss-2-159] In addition, cerebral blood flow is altered during sleep and wakefulness among adults with OSAS compared with controls.[@b103-nss-2-159],[@b104-nss-2-159] Elevated levels of inflammatory cytokines (proteins known to mediate inflammation, brain injury repair, neural development, and autoimmune response) and reactive oxygen species in response to hypoxia and/or sleep fragmentation have been demonstrated in adults with SDB.[@b105-nss-2-159]--[@b107-nss-2-159] Studies among adults with OSAS also suggest that the upregulation of cytokines is associated with symptoms of depression, fatigue, and daytime sleepiness.[@b106-nss-2-159] Increased inflammatory markers among children with SDB have been reported in some studies[@b108-nss-2-159]--[@b112-nss-2-159] but not others.[@b113-nss-2-159],[@b114-nss-2-159] Rodent models suggest that increased oxidative stress and upregulation of proinflammatory cytokines and inducible nitric oxide synthase (iNOS) are important contributors to both hippocampal and cortical apoptosis.[@b115-nss-2-159]--[@b117-nss-2-159] Zhan et al[@b118-nss-2-159] recently demonstrated that the pharmacological inhibition of iNOS or genetic ablation of the enzyme in mice was associated with markedly reduced brain oxidative injury. Also, using a rodent model, animals exposed to intermittent hypoxia have been shown to demonstrate increased oxidative stress within neural tissue and reduced spatial learning compared with animals exposed to room air only or those exposed to intermittent hypoxic conditions but receiving antioxidants to prevent oxidative cellular damage.[@b119-nss-2-159]

These findings have led to interest in the evaluation of the neurochemical and structural changes in OSAS, particularly in structures such as the hippocampus and prefrontal cortex, which underpin many of the functional neurobehavioral deficits shown. Using voxel-based morphometry, Macey et al[@b120-nss-2-159] demonstrated changes in gray matter concentration across multiple brain regions including the hippocampus and frontal cortex in 21 adults with OSAS compared with controls, a finding supported by Morrell et al[@b121-nss-2-159] who reported a loss of gray matter concentration in the left hippocampus of seven adults with OSAS. A more recent study from Macey et al[@b122-nss-2-159] outlined extensive white matter changes particularly in brain regions previously shown to be functionally or anatomically affected in adults with OSAS (hippocampus and amygdala, frontal, parietal, and temporal cortices). Thus, there is evolving and compelling evidence that brain structure is altered in adults with OSAS. The picture is less clear in children as few such studies have been completed.

Using proton magnetic resonance spectroscopic imaging, Halbower et al[@b52-nss-2-159] in a subset of six children with severe OSAS (mean OAHI, 37.8), demonstrated a significant decrease of the mean neuronal metabolite ratio *N*-acetyl aspartate/choline in both the left hippocampus and the right frontal cortex, indicating metabolic disturbance and possible neuronal loss. The authors speculate that untreated OSAS could permanently alter the child's developmental and academic potential. Hill et al[@b33-nss-2-159] demonstrated increased cerebral blood flow velocity in children with SDB, possibly indicating increased cerebral blood flow secondary to increased metabolic demand and/or narrowing of blood vessels. Although values were not directly associated with SDB severity or executive function performance and processing speed, differences between SDB children and controls for performance on neuropsychological tasks were reduced when controlling for blood flow velocity. Following treatment, the same group was able to demonstrate a reduction in cerebral blood flow among children with SDB. This occurred despite continued deficits in executive functioning.[@b81-nss-2-159]

A recent series of studies has postulated that individual differences in systemic inflammatory response to hypoxia (and/or sleep fragmentation) may explain differential outcomes to SDB in children.[@b55-nss-2-159],[@b58-nss-2-159],[@b123-nss-2-159] Levels of the inflammatory marker, high-sensitivity C-reactive protein (hsCRP), were higher among children with OSAS compared with both controls and snorers, while global neurocognitive ability was reduced in the OSAS group. Of note, a subgroup of snoring children with reduced neurocognitive scores also demonstrated elevated hsCRP levels. Furthermore, children with OSAS and lower neurocognitive scores demonstrated elevated hsCRP levels compared with matched children with OSAS and normal neurocognitive scores.[@b55-nss-2-159] A second study found lower plasma concentrations of the neuroprotective insulin-like growth factor-1 in children with OSAS and neurocognitive deficits compared with children with OSAS and normal neurocognitive functioning.[@b58-nss-2-159] Although at least one study has shown improvement in inflammatory markers among children with SDB following treatment,[@b124-nss-2-159] it is not known whether related improvements in neurocognitive function follow. Finally, apparent individual susceptibility may, at least in part, be genetically determined. A familial aggregation of SDB in children has been reported, suggesting increased SDB risk to be at least in part a heritable trait.[@b125-nss-2-159],[@b126-nss-2-159] Recently, the chromosomal region containing the apolipoprotein E (*ApoE*) gene has been implicated as a disease susceptibility locus for SDB.[@b127-nss-2-159] This result has been confirmed in child SDB[@b123-nss-2-159],[@b128-nss-2-159] and, in addition, it was found that children with both SDB and neurocognitive deficits demonstrated greatest expression of the *ApoE* ɛ4 allele (presumably resulting in reduced neuroprotection). Investigation of the genetic underpinnings of SDB is extremely limited to date, and hence, further studies mapping target gene regions are required.

Irrespective of the specific causal pathway of neurocognitive and behavioral deficits in children with SDB, the age of SDB onset is a potential moderator of residual deficits. Cumulative effects or earlier point of insult during a period of rapid neural development may result in greater severity and range of deficits. Studies of cortical maturation suggest that the neuronal overproduction and subsequent pruning throughout childhood develop in parallel to a range of neurocognitive milestones.[@b129-nss-2-159]--[@b131-nss-2-159] Neuronal insults in childhood are assumed to result in less structural and functional deficits compared with adults due to the brain's ability to compensate or modify by taking advantage of such neuronal overproduction and subsequent alternate synaptic pathways. Proponents of this idea point to the evidence from good outcomes for children with focal neuronal insults.[@b132-nss-2-159],[@b133-nss-2-159] others argue that this same increased interconnectivity combined with brain immaturity and limited established neurocognitive skills may place younger children at increased risk of functional and cumulative deficits following brain insults.[@b134-nss-2-159] In the latter case, it is considered that unless a certain function is learned during a critical or sensitive period of development, the function in question will be permanently lost or disadvantaged. Chugani[@b135-nss-2-159] has demonstrated that dramatic increases in brain metabolism occur between the ages of 1 and 4 years and that the high levels of metabolism are maintained up until 9--10 years. The author suggest that repeated activation of certain neuronal circuits during this period (by practice at tasks dependent on such circuits) results in stabilization of those circuits and that attempts after this time may be too late for promotion of such stabilization. One would expect that this period of increased metabolic activity represents the overlay of multiple pathways each subserving different neurocognitive functions. Coincident with this, we see an increased potential for plasticity, together supporting efforts to stabilize specific functions while the opportunity exists. Disruption of processes important for neuronal metabolism among children with SDB by increased inflammation, vascular responsiveness, and reduced opportunity for consolidation of learning may lead to long-term deficits depending on the timing of illness and treatment.

In addition to the timing of SDB onset and treatment, interindividual differences in cortical development may cause additional variation in the timing of sensitive periods for specific neurocognitive domains and subsequent vulnerability for neurocognitive deficits. Cortical growth has been shown to follow varying trajectories in children with different levels of intelligence.[@b136-nss-2-159] It is suggested that due to the later structural and metabolic maturation of the frontal and prefrontal cortex in more intelligent children and the prolonged phase of this maturation, an extended critical period of neurocognitive development might be afforded to such children. Consistent with this notion, Mahone et al[@b137-nss-2-159] found that children with ADHD and above-average IQ scores performed no worse on tests of executive function than controls with an equivalent IQ. In contrast, children with ADHD and average IQ scores demonstrated worse performance compared with IQ equivalent controls. Adults with SDB and high intelligence demonstrated attention and alertness performance equivalent to high-intelligence controls. In contrast, patients with average intelligence demonstrated reduced attention and alertness performance compared with average-intelligence controls.[@b138-nss-2-159] High intelligence may serve to prevent clinical impairment by providing greater reserve of neurocognitive function to compensate for neuronal insults, and in doing so suggests that increased neuronal plasticity plays an important part within the context of sensitive periods of neurocognitive development. This is yet to be evaluated among children with SDB.

Conclusion
==========

Our critical review of neurocognition and behavior in children with SDB before and after treatment suggests firstly that before treatment, children with any degree of SDB demonstrate neurocognitive impairment compared with controls or standardized norms. This impairment is most apparent for domains highly dependent on frontal -- cortical processes including executive function, attention, subsequent general intellectual ability, and to a lesser extent language development. However, compared with control samples the reductions in general intelligence are typically within the normal range. Associations with SDB severity support the concept of a direct impact of SDB on frontal cortical functions as SDB severity was most consistently correlated with reduced executive function; however, the role of nonspecific sleep disruption and the potential mediating role of attention and/or executive deficits are yet to be investigated among children with SDB. Secondly, the pattern of behavioral problems among children with SDB is less clear. A number of studies report problematic behavior in children with SDB; however, such problems are evident in less than half of the studies included. In contrast to the previous reports, evidence from well-conducted studies does not indicate inattentiveness and hyperactivity to be more prevalent than other problematic behaviors such as depression, somatic complaints, and social problems. Significant associations between behavior and SDB severity are evident in a very few studies, suggesting that other mediating factors related to general sleep disruption such as daytime sleepiness are at play in regulating behavior among children with SDB.

Of the treatment studies to date, the majority assess treatment effects among primary school-aged children with little follow-up data extending beyond 1 year. In addition, only a very small number of studies assess preschool-aged children, a period of life deemed critical in neurocognitive development. The key finding from treatment studies is that very few studies provide follow-up PSG to quantify posttreatment SDB severity, and similarly few studies include control data at both baseline and follow-up time points, making it difficult to establish clear patterns of treatment response. From the wider literature, neurocognitive performance improvements in global intelligence, attention, and visual--spatial ability are relatively consistent. In contrast, deficits in language and short-term memory appear to persist. Little data are available to determine whether improvements in executive deficits are likely. For behavior, problems of hyperactivity, aggression or conduct problems, and somatic complaints improve following adenotonsillectomy. In contrast, symptoms of anxiety and reported social problems do not appear to improve. Despite the reported behavior improvements, baseline reports often suggest no clinically significant problem.

The characterization of the pattern of neurocognitive deficits and problematic behavior in children with SDB provided by this review will aid in the development of more targeted investigations and well-designed studies exploring both the causative mechanisms and the treatment response. A number of theoretical models have been put forward, which require substantiation in well-designed studies if we are to delineate the pathways linking SDB to neurocognitive deficits and to understand the failure in some cases for neurocognitive deficits to resolve with treatment. In addition, the timing of intervention in children and consideration of individual development may also contribute to variations in treatment efficacy. Given the high prevalence of child SDB reported in the community and the potential long-term impact on the quality of life and health, and an individual's academic and occupational success, further investigations and development of effective strategies to identify the symptoms early and prevent residual deficits are needed.
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###### 

Comparisons of neurocognitive function between children with and without SDB

  Authors                                           Global intelligence   Verbal intelligence   Nonverbal intelligence   Memory                                        Attention                                     Executive function   Language        Visual spatial   Sensorimotor
  ------------------------------------------------- --------------------- --------------------- ------------------------ --------------------------------------------- --------------------------------------------- -------------------- --------------- ---------------- --------------
  Rhodes et al[@b45-nss-2-159]                      \+                    NA                    NA                       \+                                            NA                                            NA                   NA              NA               NA
  Blunden et al[@b31-nss-2-159]                     \+                    \+                    \+                       \+                                            \+                                            NA                   NA              NA               NA
  Owens et al[@b46-nss-2-159],^\*^                  ○                     ○                     NA                       ○                                             \+                                            \+                   o               ○                \+
  Hansen and Vandenberg[@b47-nss-2-159],^\*^        NA                    NA                    NA                       ○                                             \+                                            NA                   NA              NA               NA
  Lewin et al[@b19-nss-2-159]                       ○                     ○                     ○                        NA                                            NA                                            NA                   NA              NA               NA
  Friedman et al[@b16-nss-2-159]                    \+                    ○                     NA                       \+                                            NA                                            NA                   NA              ○                NA
  Kaemingk et al[@b48-nss-2-159]                    ○                     ○                     ○                        \+                                            NA                                            NA                   ○               NA               NA
  Archbold et al[@b49-nss-2-159],^\*^               ○                     NA                    NA                       ○                                             \+                                            ○                    ○               NA               NA
  Beebe et al[@b24-nss-2-159]                       ○                     NA                    NA                       ○                                             ○                                             \+                   NA              NA               NA
  Gottlieb et al[@b17-nss-2-159]                    \+                    ○                     \+                       \+                                            \+                                            \+                   NA              NA               NA
  Kennedy et al[@b50-nss-2-159]                     \+                    \+                    ○                        \+                                            \+                                            NA                   NA              NA               NA
  O'Brien et al[@b27-nss-2-159]                     \+                    ○                     \+                       ○                                             \+                                            \+                   \+              ○                NA
  O'Brien et al[@b51-nss-2-159]                     \+                    \+                    ○                        \+                                            ○                                             ○                    \+              \+               NA
  O'Brien et al[@b26-nss-2-159]                     \+                    \+                    \+                       ○                                             \+                                            ○                    \+              \+               NA
  Montgomery-Downs et al[@b15-nss-2-159]            \+                    NA                    NA                       NA                                            NA                                            NA                   ○               NA               NA
  Chervin et al[@b43-nss-2-159]                     NA                    NA                    NA                       NA                                            \+                                            NA                   NA              NA               NA
  Galland et al[@b32-nss-2-159]                     NA                    NA                    NA                       NA                                            \+                                            NA                   NA              NA               NA
  Halbower et al[@b52-nss-2-159]                    \+                    NA                    NA                       ○                                             o                                             \+                   NA              ○                ○
  Hill et al[@b33-nss-2-159]                        ○                     ○                     ○                        NA                                            \+                                            \+                   NA              ○                NA
  Kurnatowski et al[@b34-nss-2-159]                 NA                    NA                    NA                       \+                                            \+                                            \+                   \+              \+               \+
  Li et al[@b53-nss-2-159],^a^                      NA                    NA                    NA                       NA                                            \+                                            NA                   NA              NA               NA
  Ziliotto et al[@b54-nss-2-159]                    NA                    NA                    NA                       \+                                            NA                                            NA                   NA              NA               NA
  Gozal et al[@b55-nss-2-159]                       \+                    NA                    NA                       NA                                            NA                                            NA                   NA              NA               NA
  Uema et al[@b56-nss-2-159]                        NA                    NA                    NA                       \+                                            ○                                             NA                   NA              NA               NA
  Calhoun et al[@b57-nss-2-159]                     ○                     ○                     \+                       ○                                             ○                                             ○                    NA              ○                NA
  Giordani et al[@b25-nss-2-159]                    NA                    ○                     NA                       \+[a](#tfn1-nss-2-159){ref-type="table-fn"}   \+                                            ○                    ○               \+               ○
  Gozal et al[@b58-nss-2-159]                       \+                    \+                    ○                        ○                                             ○                                             \+                   \+              ○                ○
  Kohler et al[@b18-nss-2-159]                      \+                    \+                    \+                       \+[b](#tfn2-nss-2-159){ref-type="table-fn"}   \+[c](#tfn3-nss-2-159){ref-type="table-fn"}   \+                   \+              \+               \+
  Studies showing impairment in children with SDB   13/20 (65%)           6/15 (40%)            6/12 (50%)               12/21 (57.1%)                                 15/21 (71.4%)                                 9/14 (64.3%)         6/1 1 (54.5%)   5/12 (41.7%)     3/6 (50%)

Compared to standardized norms only.

Giordani et al[@b25-nss-2-159] report deficits in recall of dot patterns but not for recall of faces, verbal stories, or words.

Kohler et al[@b18-nss-2-159] report deficits in recall of verbal stories but not recall of faces or words.

Kohler et al[@b18-nss-2-159] report deficits in visual but not auditory attention.

**Note:** "+" indicates significant deficits in SDB children shown and "o" indicates significant deficits in SDB children not shown.

**Abbreviation:** NA, not assessed.

###### 

Association of neurocognitive function with SDB severity among children

  Authors                                                               Global intelligence   Verbal intelligence   Nonverbal intelligence   Memory        Attention     Executive function   Language    Visual spatial   Sensorimotor
  --------------------------------------------------------------------- --------------------- --------------------- ------------------------ ------------- ------------- -------------------- ----------- ---------------- --------------
  Rhodes et al[@b45-nss-2-159]                                          NA                    NA                    NA                       \+            NA            NA                   ○           NA               NA
  Lewin et al[@b19-nss-2-159]                                           ○                     \+                    ○                        NA            NA            NA                   NA          NA               NA
  Kaemingk et al[@b48-nss-2-159]                                        \+                    ○                     \+                       \+            NA            NA                   \+          NA               NA
  Archbold et al[@b49-nss-2-159]                                        NA                    NA                    NA                       NA            NA            \+                   NA          NA               NA
  Beebe et al[@b24-nss-2-159]                                           ○                     NA                    NA                       ○             \+            \+                   NA          NA               NA
  Kennedy et al[@b50-nss-2-159]                                         \+                    \+                    \+                       \+            ○             NA                   NA          NA               NA
  O'Brien et al[@b27-nss-2-159]                                         \+                    ○                     \+                       ○             \+            \+                   ○           ○                NA
  Chervin et al[@b43-nss-2-159]                                         NA                    NA                    NA                       NA            ○             NA                   NA          NA               NA
  Galland et al[@b32-nss-2-159]                                         NA                    NA                    NA                       NA            ○             NA                   NA          NA               NA
  Li et al[@b53-nss-2-159]                                              NA                    NA                    NA                       NA            \+            NA                   NA          NA               NA
  Suratt et al[@b59-nss-2-159]                                          \+                    ○                     NA                       ○             ○             NA                   NA          ○                NA
  Calhoun et al[@b57-nss-2-159]                                         ○                     ○                     ○                        ○             ○             ○                    NA          ○                NA
  Kohler et al[@b18-nss-2-159]                                          ○                     ○                     ○                        ○             ○             ○                    ○           ○                ○
  Studies showing association between neurocognition and SDB severity   4/8 (50%)             2/7 (28.6%)           3/6 (50%)                3/8 (37.5%)   3/9 (33.3%)   3/5 (60%)            1/4 (25%)   0/4 (0%)         0/1 (0%)

**Note:** "+" indicates significant association shown and "○" indicates significant association not shown. Associations in the abovementioned studies were determined using a range of statistical techniques including Pearson correlations, Spearman's rho correlations, linear regression, logistic regression, and analysis of variance. Due to the limited number of studies and variation in sleep measures reported, SDB severity represents measures of hypoxia and/or respiratory-related arousals and/or frequency of respiratory events.

**Abbreviation:** NA, not assessed.

###### 

Comparisons of daytime behavior between children with and without SDB

  Authors                                           Inattention                                    Hyperactivity   Anxiety                                       Depression   Aggression/oppositional                        Social problems                                Withdrawn     Somatic complaints
  ------------------------------------------------- ---------------------------------------------- --------------- --------------------------------------------- ------------ ---------------------------------------------- ---------------------------------------------- ------------- ---------------------------------------------
  Blunden et al[@b31-nss-2-159]                     ○                                              NA              ○                                             ○            ○                                              ○                                              ○             ○
  Owens et al[@b46-nss-2-159],^\*^                  ○                                              ○               ○                                             NA           ○                                              NA                                             NA            \+
  Lewin et al[@b19-nss-2-159]                       ○                                              NA              \+                                            \+           ○                                              \+                                             ○             \+
  Gottlieb et al[@b60-nss-2-159]                    \+                                             ○               NA                                            NA           NA                                             NA                                             NA            NA
  Kaemingk et al[@b48-nss-2-159]                    ○                                              ○               NA                                            NA           NA                                             NA                                             NA            NA
  Kohyama et al[@b61-nss-2-159]                     \+                                             NA              \+                                            \+           ○                                              \+                                             \+            \+
  Beebe et al[@b24-nss-2-159]                       ○                                              \+              ○                                             ○            \+                                             NA                                             NA            NA
  Crabtree et al[@b62-nss-2-159]                    NA                                             NA              NA                                            \+           NA                                             \+                                             NA            NA
  Melendres et al[@b41-nss-2-159]                   NA                                             \+              NA                                            NA           NA                                             NA                                             NA            NA
  O'Brien et al[@b27-nss-2-159]                     ○                                              ○               ○                                             ○            ○                                              ○                                              ○             ○
  O'Brien et al[@b51-nss-2-159]                     \+                                             ○               ○                                             NA           ○                                              ○                                              NA            ○
  O'Brien et al[@b26-nss-2-159]                     \+                                             \+              \+                                            \+           ○                                              \+                                             \+            NA
  Mulvaney et al[@b63-nss-2-159]                    \+                                             ○               ○                                             ○            \+                                             \+                                             ○             ○
  Chervin et al[@b43-nss-2-159]                     NA                                             \+              NA                                            NA           NA                                             NA                                             NA            NA
  Galland et al[@b32-nss-2-159],^\*^                \+                                             \+              ○                                             \+           \+                                             ○                                              ○             \+
  Mitchell and Kelly[@b64-nss-2-159],^\*^           NA                                             ○               NA                                            ○            ○                                              NA                                             NA            \+
  Suratt et al[@b59-nss-2-159]                      ○                                              ○               ○                                             NA           ○                                              ○                                              NA            ○
  Constantin et al[@b65-nss-2-159],^\*^             ○                                              ○               NA                                            NA           ○                                              NA                                             NA            NA
  Dillon et al[@b66-nss-2-159]                      ○                                              ○               ○                                             ○            \+                                             NA                                             NA            NA
  Giordani et al[@b25-nss-2-159]                    \+[b](#tfn11-nss-2-159){ref-type="table-fn"}   \+              ○[a](#tfn10-nss-2-159){ref-type="table-fn"}   NA           \+[a](#tfn10-nss-2-159){ref-type="table-fn"}   \+[a](#tfn10-nss-2-159){ref-type="table-fn"}   NA            o[b](#tfn11-nss-2-159){ref-type="table-fn"}
  Zhao et al[@b30-nss-2-159]                        ○                                              ○               \+                                            \+           \+                                             \+                                             \+            \+
  Studies showing impairment in children with SDB   7/17 (41.2%)                                   6/16 (37.5%)    4/14 (28.6%)                                  6/12 (50%)   6/16 (37.5%)                                   7/12 (58.3%)                                   3/8 (37.5%)   6/12 (50.0%)

**Note:** "+" indicates more problems in SDB children shown and "○" indicates more problems in SDB children not shown.

Compared to standardized norms only;

Personal communication with author and unpublished analyses.

**Abbreviation:** NA, not assessed.

###### 

Association of behavior with SDB severity among children

  Authors                                                         Attention     Hyperactivity   Anxiety       Depression    Aggression/conduct   Social problems   Withdrawn     Somatic complaints
  --------------------------------------------------------------- ------------- --------------- ------------- ------------- -------------------- ----------------- ------------- --------------------
  Lewin et al[@b19-nss-2-159]                                     ○             NA              ○             ○             ○                    ○                 ○             ○
  Kohyama et al[@b61-nss-2-159]                                   ○             NA              ○             ○             ○                    ○                 ○             ○
  Beebe et al[@b24-nss-2-159]                                     \+            \+              ○             \+            \+                   NA                NA            NA
  Crabtree et al[@b62-nss-2-159]                                  NA            NA              NA            ○             NA                   ○                 NA            NA
  Melendres et al[@b41-nss-2-159]                                 NA            ○               NA            NA            NA                   NA                NA            NA
  O'Brien et al[@b27-nss-2-159]                                   ○             ○               ○             ○             ○                    ○                 ○             ○
  Chervin et al[@b43-nss-2-159]                                   ○             ○               NA            NA            NA                   NA                NA            NA
  Galland et al[@b32-nss-2-159]                                   ○             ○               ○             ○             ○                    ○                 ○             ○
  Li et al[@b53-nss-2-159]                                        NA            ○               ○             ○             ○                    ○                 ○             ○
  Suratt et al[@b59-nss-2-159]                                    ○             ○               ○             NA            ○                    ○                 NA            ○
  Dillon et al[@b66-nss-2-159]                                    ○             ○               ○             ○             \+                   NA                NA            NA
  Zhao et al[@b30-nss-2-159]                                      ○             ○               \+            \+            \+                   \+                \+            \+
  Studies showing association between behavior and SDB severity   1/9 (11.1%)   1/9 (11.1%)     1/9 (11.1%)   2/9 (22.2%)   3/9 (33.3%)          1/8 (12.5%)       1/6 (16.7%)   1/7 (14.3%)

**Note:** "+" indicates significant association shown and "○" indicates significant association not shown. Associations in the abovementioned studies were determined using a range of statistical techniques including Pearson correlations, Spearman's rho correlations, linear regression, logistic regression, and analysis of variance. Due to the limited number of studies and variation in sleep measures reported, SDB severity represents measures of hypoxia and/or respiratory-related arousals and/or frequency of respiratory events.

**Abbreviation:** NA, not assessed.

###### 

Summary of published studies investigating neurocognitive performance and behavior in children with SDB

  Authors                                              Population                                                                                                                                             SDB/snoring measure                                                 Neurocognitive dysfunction                                                                                                        Behavioral dysfunction                                                                                                            Note
  ---------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  Guilleminault et al[@b6-nss-2-159]                   8 OSAS (5--14 y)                                                                                                                                       PSG                                                                 Academic difficulties                                                                                                             Emotional disturbance, hyperactive, sleepiness                                                                                    Anecdotal reports only
  Guilleminault et al[@b139-nss-2-159]                 24 OSAS, 26 OSAS secondary to medical problem, 22 controls (all 1--16 y)                                                                               Esophageal pressure, PSG                                            Academic difficulties, language                                                                                                   Aggression, hyperactive, inattentive, sleepiness, withdrawn                                                                       Anecdotal reports only
  Brouillette et al[@b68-nss-2-159]                    22 OSAS (3--5 y)                                                                                                                                       Daytime PSG                                                         Not reported                                                                                                                      General behavior, sleepiness                                                                                                      Anecdotal reports and unspecified measures
  Guilleminault et al[@b7-nss-2-159]                   25 snorers, 25 controls (all 2--14 y)                                                                                                                  Esophageal pressure, PSG                                            Academic difficulties                                                                                                             Aggressive, hyperactive, sleepiness, withdrawn                                                                                    Anecdotal reports only
  Weissbluth et al[@b140-nss-2-159]                    71 behavior, academic, an development problems (6.2 ± 3.5 y); 355 controls (5.8 ± 3.1 y)                                                               Questionnaire                                                       Academic difficulties                                                                                                             Hyperactive, inattentive                                                                                                          No PSG, nonvalidated behavior measure
  Brouillette et al[@b141-nss-2-159]                   23 OSAS (3.8 ± 2.4 y), 46 controls (4.0 ± 2.3 y)                                                                                                       PSG, questionnaire                                                  NA                                                                                                                                Sleepiness, withdrawn                                                                                                             PSG in OSAS group only, nonvalidated behavior measure
  Stradling et al[@b71-nss-2-159]                      61 snorers (4.7 ± 1.7 y), 31 controls (4.7 ± 1.7 y)                                                                                                    Home oximetry and video, questionnaire                              NA                                                                                                                                Aggressive, hyperactive                                                                                                           Nonvalidated behavior measure
  Ali et al[@b142-nss-2-159]                           782 from health registrar -- 66 SDB, 66 controls (all aged 4--5 y)                                                                                     Home oximetry and video, questionnaire                              NA                                                                                                                                Aggressive, hyperactive, inattentive                                                                                              Nonvalidated behavior measure
  Carskadon et al[@b143-nss-2-159]                     29 children with adenotonsillar hypertrophy (8.7 ± 3.0 y)                                                                                              Questionnaire                                                       NA                                                                                                                                Disruptive                                                                                                                        Nonvalidated behavior measure, no control group
  Ali et al[@b69-nss-2-159]                            507 from health registrar (all aged 6.5--7.5 y) -- 56 snorers                                                                                          Questionnaire                                                       NA                                                                                                                                Hyperactive, sleepiness                                                                                                           
  Rhodes et al[@b45-nss-2-159]                         5 patients with OSAS (12.9 ± 2.1 y), 9 clinical patients with no OSAS (13.5 ± 1.5 y)                                                                   PSG                                                                 Learning, memory                                                                                                                  NA                                                                                                                                All subjects were obese
  Ali et al[@b70-nss-2-159]                            12 SDB (5--12 y), 11 snorers (6--12 y), 10 controls (6--12 y)                                                                                          Questionnaire, home nocturnal oximetry and video                    No between-group differences (IQ, attention, response speed)                                                                      Aggressive, hyperactive, inattentive                                                                                              
  Guilleminault et al[@b144-nss-2-159]                 411 sleep clinic patients (birth to 12 y)                                                                                                              Esophageal pressure, PSG                                            NA                                                                                                                                Oppositional                                                                                                                      Nonvalidated behavior measure
  Chervin et al[@b145-nss-2-159]                       27 ADHD patients (9.5 ± 3.7 y), 116 non-ADHD patients (8.9 ± 4.7 y)                                                                                    Questionnaire                                                       NA                                                                                                                                Hyperactive, inattention                                                                                                          Groups defined by ADHD symptom, nonvalidated behavior measure
  Owens-lively et al[@b146-nss-2-159]                  23 OSAS (age not reported)                                                                                                                             PSG                                                                 Attention                                                                                                                         Impulsivity and inattentiveness compared with moderate/severe OSA, mild OSA more severe hyperactivity                             No control group
  Gozal[@b72-nss-2-159]                                297 first grade children with poor academic performance (177 controls, 66 primary snorers, 30 nontreated SDB, and 24 treated SDB)                      Home oximetry and TcCO~2~, questionnaire                            Academic performance                                                                                                              NA                                                                                                                                
  Owens et al[@b147-nss-2-159]                         100 OSAS (8.9 ± 4.7 y) vs 52 behavioral sleep problems                                                                                                 PSG                                                                 NA                                                                                                                                OSAS patients displayed less problematic behavior compared with children with behavioral sleep problems                           Snoring evident in the group with behavioral sleep problems
  Harvey et al[@b80-nss-2-159]                         56 SDB (2.9 ± 1.3 y)                                                                                                                                   PSG                                                                 Not reported                                                                                                                      Not reported                                                                                                                      28%neurologicallyabnormal
  Blunden et al[@b31-nss-2-159]                        16 snorers (7.2, 5--10 y), 16 controls (7.7, 5--10 y)                                                                                                  PSG (n = 26), questionnaire                                         Attention, IQ, memory                                                                                                             No differences between groups                                                                                                     Groups not matched for SES
  Ferreira et al[@b148-nss-2-159]                      976 children (8.1 ± 1.5 y) from community (8.8% habitual snorers)                                                                                      Questionnaire                                                       NA                                                                                                                                Irritability, sleepiness                                                                                                          
  Goldstein et al[@b85-nss-2-159]                      36 snorers (4.6, 2--10 y)                                                                                                                              Questionnaire, physical examination                                 NA                                                                                                                                externalizing                                                                                                                     No control group
  Kelmanson[@b149-nss-2-159]                           200 infants---71 snorers/noisy breathing (3.0 ± 1.0 mo)                                                                                                Questionnaire                                                       NA                                                                                                                                Negative mood                                                                                                                     Nonvalidated sleep measure
  Owens et al[@b46-nss-2-159]                          18 OSAS (7.3 ± 2.0 y)                                                                                                                                  PSG                                                                 No difference between mild and moderate OSAS                                                                                      Learning problems, somatic complaints, no difference between mild and moderate OSAS                                               No control group
  Richards and Ferdman[@b73-nss-2-159]                 45 OSAS post-AT (2.5--15.5 y)                                                                                                                          PSG, questionnaire                                                  School performance                                                                                                                Sleepiness                                                                                                                        Retrospective review, no control group
  Brunetti et al[@b150-nss-2-159]                      895 school students(7.3 y, 3--11 y) -- 44 habitual snorers (4.9%)                                                                                      Questionnaire, limited home PSG (n = 34), laboratory PSG (n = 12)   Academic performance                                                                                                              Hyperactive                                                                                                                       
  Chervin and Archbold[@b151-nss-2-159]                113 sleep clinical patients (9.9 ± 4.0 y) -- 59 SDB, 54 non-SDB                                                                                        PSG                                                                 NA                                                                                                                                No reported associations                                                                                                          Non-SDB group included primary snorers
  Gozal and Pope[@b152-nss-2-159]                      797 low-performing students, 791 high-performing students (all 13--14 y)                                                                               Questionnaire                                                       Snoring more likely amongst low-performing students                                                                               NA                                                                                                                                
  Hansen and Vandenberg[@b47-nss-2-159]                7 OSAS (7.3 ± 2.0 y), 7 narcoleptics (7.3 ± 2.0 y)                                                                                                     PSG                                                                 Attention                                                                                                                         NA                                                                                                                                No control group
  Smedje et al[@b153-nss-2-159]                        635 children (84 ± 5 mo) from community (9.3% habitual snorers)                                                                                        Questionnaire                                                       NA                                                                                                                                No reported associations                                                                                                          
  Stein et al[@b154-nss-2-159]                         472 children (4--12 y) from pediatric clinic (23% snored \>1 night/wk)                                                                                 Questionnaire                                                       NA                                                                                                                                Social problems, somatic complaints                                                                                               
  Chervin and Archbold[@b151-nss-2-159]                866 children attending clinics (6.8 ± 3.2 y), 139 habitual snorers                                                                                     Questionnaire                                                       NA                                                                                                                                Snoring associated with hyperactivity                                                                                             
  Goldstein et al[@b84-nss-2-159]                      64 children awaiting AT (7.3 ± 2.0 y)                                                                                                                  Questionnaire, physical examination                                 NA                                                                                                                                All behaviors within clinical range                                                                                               No control group
  Lewin et al[@b19-nss-2-159]                          12 severe OSAS (6.6 ± 1.5 y), 16 mild OSAS (7.6 ± 3.0 y), 10 controls (6.9 ± 1.1 y)                                                                    PSG (OSAS only), questionnaire                                      Information processing, verbal IQ (associations and group differences reported for severe OSAS group and controls only)           Internalizing problems, somatic complaints, externalizing problems, anxiety/depression, social problems in mild OSAS group only   No PSG in control group
  Castronovo et al[@b156-nss-2-159]                    447 children (4.1 ± 0.9 y) from community, 154 habitual snorers                                                                                        Questionnaire, limited home PSG (n = 241)                           NA                                                                                                                                Irritable                                                                                                                         Nonvalidated behavior measure
  Chervin et al[@b22-nss-2-159]                        146 school children (9.3 ± 0.4 y)                                                                                                                      Questionnaire                                                       Teacher reports of performance but not objective test scores                                                                      NA                                                                                                                                
  Chervin et al[@b157-nss-2-159]                       872 children attending clinics (6.7 ± 3.2 y)                                                                                                           Questionnaire                                                       NA                                                                                                                                Aggression, conduct problems                                                                                                      
  Freidman et al[@b16-nss-2-159]                       39 OSAS (6.8 ± 0.2 y), 20 controls (7.4 ± 1.4 y)                                                                                                       PSG (OSAS only), questionnaire                                      Analytic thinking, auditory-visual integration, general intelligence, memory                                                      NA                                                                                                                                No PSG in control group
  Gottlieb et al[@b60-nss-2-159]                       3,019 children (all 5 y, 362 habitual snorers)                                                                                                         Questionnaire                                                       NA                                                                                                                                Aggression, hyperactive, inattentive, sleepiness                                                                                  
  Kaemingk et al[@b48-nss-2-159]                       149 school children (8.4 ± 1.7 y), 77 API ≥ 5                                                                                                          PSG                                                                 Memory                                                                                                                            None found                                                                                                                        
  Kohyama et al[@b61-nss-2-159]                        32 SDB (5.6, 4--9 y),                                                                                                                                  PSG (SDB only)                                                      NA                                                                                                                                Anxiety, inattention,                                                                                                             No sleep
                                                       137 controls (5.3, 4--6 y)                                                                                                                                                                                                                                                                                                                                   social problems, somatic complaints, thought problems, withdrawn                                                                  assessment for controls
  Montgomery-Downs et al[@b23-nss-2-159]               746 developmentally or financially disadvantaged children (4.2 ± 0.53 y)                                                                               Questionnaire                                                       School performance                                                                                                                Hyperactivity, sleepiness                                                                                                         High percentage on nonresponders
  O'Brien et al[@b13-nss-2-159]                        71 children with ADHD symptoms, 39 controls (all 5--7 y)                                                                                               PSG, questionnaire                                                  No reported effects                                                                                                               OSAS and snoring are more prevalent when ADHD symptoms are mild                                                                   Groups defined by ADHD symptoms, limited analysis of contribution of OSAS
  Shin et al[@b158-nss-2-159]                          3,871 high-school students (16.8 y), 433 habitual snorers                                                                                              Questionnaire                                                       School grades                                                                                                                     Sleepiness                                                                                                                        Nonvalidated sleep and behavior measure
  Urschitz et al[@b159-nss-2-159], [@b160-nss-2-159]   1,144 school children (9.6 ± 0.7 y), 114 habitual snorers                                                                                              Questionnaire, home nocturnal oximetry                              Mathematical, science, and spelling performance                                                                                   Attention, hyperactive, sleepiness                                                                                                
  Archbold et al[@b49-nss-2-159]                       12 children scheduled for AT (9.0 ± 0.85 y)                                                                                                            PSG                                                                 Sustained attention, vigilance                                                                                                    NA                                                                                                                                No control group
  Avior et al[@b79-nss-2-159]                          19 OSAS (8.0 y, range 5--14 y)                                                                                                                         Questionnaire, adenotonsillar hypertrophy                           Attention                                                                                                                         Attention                                                                                                                         No control group
  Beebe et al[@b24-nss-2-159]                          32 SDB (6.7 ± 0.5 y), 17 controls (6.7 ± 0.5 y)                                                                                                        PSG (SDB only), questionnaire                                       Verbal fluency                                                                                                                    Aggression, conduct problems, hyperactive                                                                                         Psychostimulants use amongst controls, no PSG for control
  Crabtree et al[@b62-nss-2-159]                       85 SDB (10.1 ± 1.5 y), 35 controls (9.6 ± 0.9 y)                                                                                                       PSG, questionnaire                                                  NA                                                                                                                                Depression, social problems                                                                                                       
  Ersu et al[@b161-nss-2-159]                          2,147 school students (8.5 ± 1.3 y), 151 habitual snorers                                                                                              Questionnaire                                                       NA                                                                                                                                Hyperactive, sleepiness                                                                                                           
  Gottlieb et al[@b17-nss-2-159]                       61 SDB, 144 controls (all 5 y)                                                                                                                         Questionnaire, PSG (n = 180)                                        Attention, executive function, hand--eye coordination, IQ, memory                                                                 ADHD symptoms, inattention                                                                                                        
  Huang et al[@b162-nss-2-159]                         88 ADHD (8.5 ± 1.9 y, 50 with OSA), 27 controls (9.0 ± 2.0 y)                                                                                          PSG, questionnaire                                                  Response time                                                                                                                     Hyperactive                                                                                                                       
  Kaditis et al[@b163-nss-2-159]                       3,680 school students (1--18 y, median age 9.8 y), 154 habitual snorers                                                                                PSG (n = 70), questionnaire                                         NA                                                                                                                                Sleepiness                                                                                                                        
  Kennedy et al[@b50-nss-2-159]                        13 snorers (7.0 ± 4.0 y), 13 controls (7.0 ± 4.0 y)                                                                                                    PSG                                                                 Attention, IQ, memory, verbal                                                                                                     NA                                                                                                                                
  Melendres et al[@b41-nss-2-159]                      108 SDB (7.0 ± 4.0 y), 72 controls (8.0 ± 4.0 y)                                                                                                       PSG (SDB only), questionnaire                                       NA                                                                                                                                Hyperactive, sleepiness                                                                                                           
  O'Brien et al[@b27-nss-2-159]                        35 SDB (6.7 ± 0.6 y), 35 controls (6.7 ± 0.5 y)                                                                                                        PSG, questionnaire                                                  Executive function, phonological processing, visual attention                                                                     No differences between groups                                                                                                     Testing on morning after PSG
  O'Brien et al[@b51-nss-2-159]                        49 high sleep pressure score (SPS) (6.7 ± 0.5 y), 150 low SPS (6.7 ± 0.5 y)                                                                            PSG, questionnaire                                                  Language, verbal IQ, visuospatial, memory                                                                                         Inattention                                                                                                                       Low SPS also displayed significant obstruction
  O'Brien et al[@b26-nss-2-159]                        87 snorers (6.6 ± 0.5 y), 31 controls (6.8 ± 0.4 y)                                                                                                    PSG, questionnaire                                                  Language, visual attention, visuospatial                                                                                          Anxiety, delinquency, depression, hyperactive, inattention, social problems, withdrawn                                            
  Rosen et al[@b164-nss-2-159]                         162 SDB (9.5 ± 0.9 y), 667 controls (9.5 ± 0.8 y)                                                                                                      Limited PSG, questionnaire                                          NA                                                                                                                                Aggressive, emotionally labile, hyperactive, oppositional, social problems, somatic complaints                                    Inclusion in SDB group could be based on parental report only
  Arman et al[@b165-nss-2-159]                         96 habitual snorers (9.3 ± 1.4 y), 190 controls (9.4 ± 1.2 y)                                                                                          Questionnaire                                                       NA                                                                                                                                ADHD symptoms, conduct problems, inattention, oppositional, sleepiness                                                            
  Blunden et al[@b166-nss-2-159]                       11 snorers (9.4 ± 1.2 y), 9 snorers + behavioral sleep problems (9.4 ± 1.2 y), 13 behavioral sleep problems (9.4 ± 1.2 y), 31 controls (9.4 ± 1.2 y)   Questionnaire                                                       Attention, verbal IQ                                                                                                              Externalizing, internalizing                                                                                                      
  Carvalho et al[@b167-nss-2-159]                      79 SDB (9.4 ± 1.2 y), 468 nonrespiratory sleep disorders (9.4 ± 1.2 y), 633 controls (9.4 ± 1.2 y)                                                     Questionnaire                                                       Visual--motor ability                                                                                                             NA                                                                                                                                
  Chervin[@b168-nss-2-159]                             229 children from clinics (10.6 ± 3.1 y), 28 habitual snorers                                                                                          Questionnaire                                                       NA                                                                                                                                Hyperactive                                                                                                                       
  Goodwin et al[@b169-nss-2-159]                       480 school students (9.4 ± 1.2 y), 115 SDB (RDI ≥ 1)                                                                                                   Unattended home PSG                                                 Learning problems                                                                                                                 Sleepiness                                                                                                                        Nonvalidated behavior measure
  Montgomery-Downs et al[@b15-nss-2-159]               19 OSAS (4.2 ± 0.8 y), 19 controls (4.3 ± 0.7 y)                                                                                                       PSG, questionnaire                                                  IQ, verbal fluency                                                                                                                NA                                                                                                                                
  Mulvaney et al[@b63-nss-2-159]                       403 school students (9.4 ± 1.2 y), 63 SDB, 340 controls                                                                                                Unattended home PSG                                                 NA                                                                                                                                ADHD symptoms, aggressive, emotional lability, inattention, oppositional, social problems, thought problems                       Controls displayed significant respiratory disturbance
  Sogut et al[@b170-nss-2-159]                         1,198 school children (8.1 ± 1.9 y), 39 habitual snorers                                                                                               PSG (28 snorers), questionnaire                                     School grades                                                                                                                     Sleepiness                                                                                                                        Nonvalidated behavior measure
  Tran et al[@b78-nss-2-159]                           42 children scheduled for AT (5.8 ± 2.5 y), 41 children scheduled for unrelated surgery (7.3 ± 3.8 y)                                                  PSG (AT group only)                                                 NA                                                                                                                                Presurgery comparisons not made, but all mean scores within normal range for both groups                                          No PSG for control
  Urschitz et al[@b171-nss-2-159]                      995 school students (9.6 ± 0.7 y, 99 habitual snorers)                                                                                                 Questionnaire, home nocturnal oximetry                              Mathematical ability                                                                                                              NA                                                                                                                                
  Chervin et al[@b43-nss-2-159]                        78 children scheduled for adenotonsillectomy (8.1 ± 1.8 y), 27 controls (9.3 ± 2.0 y)                                                                  esophageal pressure, PSG, questionnaire                             Attention                                                                                                                         ADHD symptoms, hyperactive, sleepiness                                                                                            Some controls demonstrated SDB
  Emancipator et al[@b172-nss-2-159]                   164 SDB (9.4 ± 0.8 y), 671 non-SDB (9.4 ± 0.8 y), all children from community sample                                                                   Limited PSG, questionnaire                                          Executive function, information processing, language comprehension, verbal problem solving                                        NA                                                                                                                                
  Galland et al[@b32-nss-2-159]                        61 children scheduled for adenotonsillectomy (7.0 ± 2.0 y)                                                                                             Limited PSG, questionnaire                                          Attention, impulsivity                                                                                                            Aggression, depression, hyperactive, inattention, somatic complaints                                                              No control group
  Halbower et al[@b52-nss-2-159]                       19 OSAS (10.0 ± 2.5 y), 12 controls (9.8 ± 2.6 y)                                                                                                      PSG                                                                 Executive function, IQ                                                                                                            NA                                                                                                                                5/19 OSAS children had ADHD diagnosis
  Hill et al[@b33-nss-2-159]                           21 scheduled for adenotonsillectomy (5.5 ± 1.3 y), 17 controls (5.5 ± 1.4 y)                                                                           PSG (SDB only), questionnaire                                       Attention, processing speed                                                                                                       NA                                                                                                                                No PSG for control
  Kurnatowski et al[@b34-nss-2-159]                    117 SDB (9.4 ± 1.2 y), 104 controls (9.4 ± 1.2 y)                                                                                                      PSG                                                                 Attention, executive function, memory, verbal comprehension, visuospatial                                                         NA                                                                                                                                30% controls demonstrated snoring
  Li et al[@b53-nss-2-159]                             40 referred for adenotonsillar hypertrophy (8.4 ± 1.6 y)                                                                                               PSG                                                                 Attention                                                                                                                         No association with SDB severity                                                                                                  No control group
  Mitchell and Kelly[@b64-nss-2-159]                   23 OSAS (9.4 ± 1.2 y)                                                                                                                                  PSG                                                                 NA                                                                                                                                Somatic complaints                                                                                                                No control group
  Suratt et al[@b59-nss-2-159]                         114 with adenotonsillar hypertrophy (8.5 ± 1.9 y)                                                                                                      PSG, questionnaire                                                  verbal reasoning, vocabulary                                                                                                      Somatic complaints                                                                                                                No control group
  Ziliotto et al[@b54-nss-2-159]                       10 oral breathing and SDB (7.6 y), 10 oral breathing and SDB (8.1 y), 10 controls (7.5 y)                                                              PSG (oral breathing groups only)                                    Memory for sounds (auditory processing)                                                                                           NA                                                                                                                                No PSG for control
  Constantin et al[@b65-nss-2-159]                     138 sleep clinic patients (5.5 ± 3.0 y)                                                                                                                PSG                                                                 NA                                                                                                                                No difference between OSAS and non-OSAS                                                                                           Retrospective behavior assessment, no control group
  Dillon et al[@b66-nss-2-159]                         78 children scheduled for adenotonsillectomy (8.1 ± 1.8 y), 27 controls (9.3 ± 2.0 y)                                                                  PSG                                                                 NA                                                                                                                                ADHD symptoms, oppositional                                                                                                       Some controls demonstrated SDB
  Gozal et al[@b55-nss-2-159]                          102 OSAS (6.4 ± 0.4 y), 103 snorers (6.6 ± 0.3 y), 73 controls (6.3 ± 0.3 y)                                                                           PSG, questionnaire                                                  Global cognitive ability                                                                                                          NA                                                                                                                                Specific cognitive domains not specified
  Hiscock et al[@b173-nss-2-159]                       4,983 communities (4.7 ± 0.2 y)                                                                                                                        Questionnaire                                                       Verbal ability                                                                                                                    Conduct problems                                                                                                                  
  Uema et al[@b56-nss-2-159]                           24 OSAS, 37 primary snorers, 20 controls (all 6--12 y)                                                                                                 PSG                                                                 Verbal memory                                                                                                                     NA                                                                                                                                Deficits in both OSAS and primary snorers
  Wei et al[@b88-nss-2-159]                            117 referred for adenotonsillectomy (6.5 ± 1.8 y)                                                                                                      Questionnaire                                                       NA                                                                                                                                ADHD-type behavior, inattention, oppositional                                                                                     No control group, no comparison with standard norms
  Giordani et al[@b25-nss-2-159]                       40 OSAS scheduled for adenotonsillectomy (7.8 ± 1.8 y), 38 non-OSAS scheduled for adenotonsillectomy (8.4 ± 1.8 y), 26 controls (9.2 ± 2.0 y)          PSG                                                                 OSAS: attention, mathematical ability, visual memory, visuospatial; non-OSAS: mathematical ability, visual memory, visuospatial   externalizing, hyperactivity, internalizing                                                                                       Controls from unrelated surgery clinic
  Karpinski et al[@b174-nss-2-159]                     39 preschool students (4.3 ± 0.6 y)                                                                                                                    Questionnaire                                                       Executive function                                                                                                                NA                                                                                                                                Only 6 snoring children
  Moré et al[@b82-nss-2-159]                           73 snorers (4.6 ± 2.0 y)                                                                                                                               Questionnaire, PSG (61 children)                                    Memory                                                                                                                            Aggression                                                                                                                        No control group, no comparison with standard norms
  Zhao et al[@b30-nss-2-159]                           403 communities (8.3 ± 1.6 y)                                                                                                                          Unattended home PSG                                                 NA                                                                                                                                Aggression/oppositional, social problems, somatic complaints                                                                      Deficits irrespective of hypoxia severity
  Aronen et al[@b175-nss-2-159]                        43 snorers (4.9 ± 1.1 y), 46 controls (4.8 ± 1.1 y)                                                                                                    Questionnaire                                                       Auditory attention, language development, verbal ability                                                                          Anxiety, emotional lability                                                                                                       Not all children included in analyses of language and attention
  Calhoun et al[@b57-nss-2-159]                        571 communities (413 controls, 8.7 ± 1.6 y; 158 SDB, 8.7 ± 1.7 y)                                                                                      PSG                                                                 Nonverbal IQ (snoring + OSA vs nonsnoring + no OSA)                                                                               NA                                                                                                                                
  Ericsson et al[@b89-nss-2-159]                       67 referred for tonsillar hypertrophy (all 4.5--5.5 y)                                                                                                 None                                                                NA                                                                                                                                Internalizing                                                                                                                     No control group, no measure of SDB
  Gozal et al[@b58-nss-2-159]                          87 OSAS (6.4 ± 0.5 y), 52 controls (6.1 ± 0.4 y)                                                                                                       PSG                                                                 Executive function, language development, mathematical ability, verbal ability                                                    NA                                                                                                                                
  Kohler et al[@b18-nss-2-159]                         44 SDB (6.6 ± 2.6 y), 48 controls (7.7 ± 2.6 y)                                                                                                        PSG                                                                 Executive function, IQ, language development, sensorimotor, verbal memory, visuospatial                                           NA                                                                                                                                
  Lundeborg et al[@b83-nss-2-159]                      67 referred for tonsillar hypertrophy (4.8 ± 0.4 y), 47 controls (4.8 ± 0.4 y)                                                                         None                                                                Language development (phonological processing)                                                                                    NA                                                                                                                                No measure of SDB

**Abbreviations:** AT, adenotonsillectomy; SDB, sleep-disordered breathing; OSAS, obstructive sleep apnea syndrome; PSG, polysomnography; TcCO~2~, transcutaneous CO~2~ monitoring; IQ, intelligence quotient; NA, not assessed.

###### 

Summary of published studies investigating changes in neurocognitive performance and behavior following treatment for SDB amongst children

  Study                                    Baseline population               Follow-up population              SDB measure                                                                                 Intervention                                                        Follow-up period                              Neurocognitive effects                                                                                                                                                         Behavior effects
  ---------------------------------------- --------------------------------- --------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------- --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Guilleminault et al[@b6-nss-2-159]       8 OSAS                            7 OSAS                            PSG                                                                                         AT (n = 5), tracheotomy (n = 2)                                     3 and 6 wk (AT), 22 and 28 mo (tracheotomy)   ↑School performance                                                                                                                                                            ↓Daytime sleepiness
  Brouillette et al[@b68-nss-2-159]        22 OSAS                           22 OSAS                           Daytime or nighttime PSG                                                                    Adenoidectomy and/or tonsillectomy (n = 11), tracheotomy (n = 11)   Not specified                                 NA                                                                                                                                                                             ↓Daytime sleepiness and ↓behavioral disturbance (n = 5)
  Guilleminault et al[@b7-nss-2-159]       25 snorers, 25 controls           25 snorers                        PSG, esophageal pressure                                                                    AT (snoring only)                                                   12 mo                                         ↑School performance (by 3 mo), ↑attention (n = 5)                                                                                                                              ↓Hyperactivity (by 6 mo), ↓daytime sleepiness (n = 5)
  Stradling et al[@b71-nss-2-159]          61 snorers, 31 controls           58 snorers, 31 controls           Oximetry, video (26 snorers and 27 controls)                                                AT (snoring only)                                                   6 mo                                          NA                                                                                                                                                                             ↓Hyperactivity and ↓aggression/rebelliousness
  Ali et al[@b70-nss-2-159]                12 SDB, 11 snorers, 10 controls   12 SDB, 11 snorers, 10 controls   Oximetry, video                                                                             AT (SDB and snoring only)                                           3--4 mo                                       SDB: ↑vigilance, no difference in impulsivity; snoring: no difference in impulsivity                                                                                           SDB: ↓aggression, inattention and hyperactivity; snoring: ↓Hyperactivity
  Gozal[@b72-nss-2-159]                    120 SDB, 177 controls             120 SDB, 177 controls             Oximetry, TcCO~2~                                                                           AT (24 SDB only)                                                    15 mo                                         ↑Academic performance in treated SDB children                                                                                                                                  NA
  Harvey et al[@b80-nss-2-159]             56 SDB                            42 SDB                            PSG                                                                                         AT (24 SDB only)                                                    6 mo                                          No change in mental development                                                                                                                                                NA
  Goldstein et al[@b85-nss-2-159]          36 SDB                            15 SDB                            Questionnaire                                                                               AT                                                                  3 mo                                          NA                                                                                                                                                                             ↓internalizing, withdrawn and somatic complaints, anxiety, depression, inattention and hyperactivity
  Owens et al[@b46-nss-2-159]              18 OSAS                           8 OSAS                            PSG                                                                                         AT                                                                  \~7 mo                                        ↑executive function, ↑motor skills; no change in IQ, language, memory, visual perception/motor ability                                                                         No change in internalizing, externalizing, and somatic complaints, attention, anxiety, hyperactivity
  Richards and Ferdman[@b73-nss-2-159]     NA                                45 OSAS                           PSG, questionnaire                                                                          AT                                                                  6--18 mo                                      Poor school performance despite treatment                                                                                                                                      Daytime sleepiness despite treatment
  Hansen and Vandenberg[@b47-nss-2-159]    7 OSAS, 7 narcoleptics            7 OSAS, 7 narcoleptics            PSG                                                                                         Unspecified surgery and CPAP (OSAS only)                            Not specified                                 ↑Memory, ↑visual attention; no change in verbal attention                                                                                                                      NA
  Goldstein et al[@b84-nss-2-159]          64 OSAS                           64 OSAS                           Clinical history, physical examination                                                      AT                                                                  3 mo                                          NA                                                                                                                                                                             ↓internalizing, externalizing, withdrawn, and somatic complaints, anxiety, depression, inattention and aggression
  Friedman et al[@b16-nss-2-159]           39 OSAS, 20 controls              27 OSAS, 14 controls              PSG (OSAS only), questionnaire                                                              AT (OSAS only)                                                      6--10 mo                                      ↑Analytic thinking, perceptual ability, visuospatial ability, intelligence, verbal memory; no change in vocabulary and memory for numbers                                      NA
  Avior et al[@b79-nss-2-159]              19 OSAS                           19 OSAS                           Questionnaire, physical examination                                                         AT                                                                  2 mo                                          ↑Attention                                                                                                                                                                     ↑Attention
  Montgomery-Downs et al[@b15-nss-2-159]   19 OSAS, 19 controls              19 OSAS                           PSG, questionnaire                                                                          AT (OSAS only)                                                      3--6 mo                                       ↑IQ; no change for language development                                                                                                                                        NA
  Tran et al[@b78-nss-2-159]               42 OSAS, 41 controls              42 OSAS, 41 controls              PSG (OSAS only)                                                                             AT (OSAS only)                                                      3 mo                                          NA                                                                                                                                                                             ↓Internalizing, thought problems and somatic complaints; no change in externalizing and withdrawn behavior, inattention, aggression, anxiety or depression
  Chervin et al[@b43-nss-2-159]            78 SDB, 27 controls               77 SDB, 23 controls               PSG                                                                                         AT                                                                  12 mo                                         ↑Attention                                                                                                                                                                     ↓Hyperactivity and sleepiness
  Galland et al[@b32-nss-2-159]            61 suspected SDB or tonsillitis   61 suspected SDB or tonsillitis   Limited PSG, questionnaire                                                                  AT                                                                  3 mo                                          ↑Visual attention; no change for auditory attention                                                                                                                            ↓Internalizing, externalizing and somatic complaints, inattention, hyperactivity, aggression and anxiety
  Li et al[@b53-nss-2-159]                 40 suspected SDB                  40 suspected SDB                  PSG                                                                                         AT                                                                  6 mo                                          ↑Attention                                                                                                                                                                     ↓Internalizing, externalizing and somatic complaints, inattention, depression, hyperactivity and anxiety; no change in aggression
  Mitchell and Kelly[@b64-nss-2-159]       23 OSAS                           23 OSAS                           PSG                                                                                         AT                                                                  6 mo and 9--18 mo                             NA                                                                                                                                                                             ↓Internalizing, externalizing and somatic complaints, depression, hyperactivity and aggression
  Roemmich et al[@b86-nss-2-159]           54 OSAS                           54 OSAS                           PSG                                                                                         AT                                                                  12 mo                                         NA                                                                                                                                                                             ↓Hyperactivity
  Constantin et al[@b65-nss-2-159]         94 SDB                            94 SDB                            PSG                                                                                         AT (n = 54)                                                         \~4 y (retrospective reports only)            NA                                                                                                                                                                             No change in oppositional behavior, inattention and hyperactivity
  Dillon et al[@b66-nss-2-159]             79 SDB, 27 controls               78 SDB, 23 controls               PSG                                                                                         AT                                                                  12 mo                                         NA                                                                                                                                                                             ↓Oppositional behavior; however, differences still evident post-AT; no change in anxiety and depression; ↓inattention and hyperactivity no greater than for controls
  Wei et al[@b88-nss-2-159]                117 SDB                           71 SDB                            Questionnaire                                                                               AT                                                                  6 mo                                          NA                                                                                                                                                                             ↓Inattention, hyperactivity and oppositional behavior
  Hogan et al[@b81-nss-2-159]              19 SDB, 14 controls               19 SDB, 14 controls               PSG (SDB, baseline only), oximetry and questionnaire (n = 16 SDB, baseline and follow-up)   AT                                                                  11 mo (SDB), 13 mo (control), *P* \< 0.001    ↑Processing speed; trend for ↑ in visual attention; no change for executive function                                                                                           NA
  Moré et al[@b82-nss-2-159]               73 SDB                            44 SDB                            PSG (n = 29), questionnaire                                                                 AT                                                                  9 mo                                          ↑Concentration, memory, school performance and ↓speech delay (parent report only)                                                                                              ↓Aggressiveness and hyperactivity
  Ericsson et al[@b89-nss-2-159]           67 SDB                            67 SDB                            Clinical examination                                                                        TE (n = 32), TT (n = 35)                                            6 mo                                          NA                                                                                                                                                                             TE: ↓somatic complaints, anxiety, inattention, social problems (no change in withdrawn behavior, aggression, thought problems); TT: ↓somatic complaints, aggression (no change in withdrawn behavior, anxiety, inattention, social and thought problems)
  Lundeborg et al[@b83-nss-2-159]          67 SDB, 47 controls               64 SDB, 31 controls               Clinical examination                                                                        TE (n = 32), TT (n = 35)                                            6 mo                                          ↑Language development; however, deficits still evident posttreatment                                                                                                           NA
  Kohler et al[@b18-nss-2-159]             44 SDB, 48 controls               44 SDB, 48 controls               PSG                                                                                         AT                                                                  6 mo                                          ↑Visuospatial ability, however, deficits still evident posttreatment; no change in IQ, executive function, attention, language development, sensorimotor function and memory   NA
  Wei et al[@b87-nss-2-159]                71 SDB                            44 SDB                            Questionnaire                                                                               AT                                                                  2.4--3.6 y                                    NA                                                                                                                                                                             ↓Inattention, hyperactivity, and oppositional behavior; no change in ADHD symptoms

**Abbreviations:** AT, adenotonsillectomy; SDB, sleep-disordered breathing; OSAS, obstructive sleep apnea syndrome; PSG, polysomnography; TcCO~2~, transcutaneous CO~2~ monitoring; TE, tonsillectomy; TT, intracapsular tonsillectomy/tonsillotomy; IQ, intelligence quotient; NA, not assessed.
